Remus Pharmaceuticals Ltd
Price Range
-
-
Min. Quantity
-
Closes on
-
-
Min. investment
-
Remus Pharmaceuticals Ltd IPO Timeline
Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad.
| Event | Date |
|---|---|
| Remus Pharmaceuticals Ltd IPO Opening Date | 17 May 2023 |
| Remus Pharmaceuticals Ltd IPO Closing Date | 19 May 2023 |
| Basis of Allotment | 24 May 2023 |
| Initiation of Refunds | 25 May 2023 |
| Credit of Shares to Demat | 26 May 2023 |
| Remus Pharmaceuticals Ltd IPO Listing Date | 29 May 2023 |
Remus Pharmaceuticals Ltd IPO Details
| Remus Pharmaceuticals Ltd IPO Date | - |
| Remus Pharmaceuticals Ltd IPO Face Value | - |
| Remus Pharmaceuticals Ltd IPO Price | - |
| Remus Pharmaceuticals Ltd IPO Lot Size | - |
| Issue Size | - |
| Fresh Issue | - |
| Offer for Sale | - |
| Issue Type | - |
| Listing At | - |
| QIB Shares Offered | - |
| Retail Shares Offered | - |
| NII (HNI) Shares Offered | - |
| Company Promoters | Arpit Deepakkumar Shah, Roma Vinodbhai Shah, Swapnil Jatinbhai Shah |
Remus Pharmaceuticals Ltd IPO Lot Size
The Remus Pharmaceuticals Ltd IPO lot size is Invalid Number shares. A retail-individual investor can apply for up to NaN lots (NaN shares or ₹NaN).
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Minimum | 1 | - | - |
| Maximum | - | - | - |
- Strengths
- Risks
- Opportunities
- -
Company Financials
Remus Pharmaceuticals Ltd Financial Information (Restated)
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 03-2024 | 98.05 | 67.19 | 16.82 |
| 03-2023 | 34.66 | 46.6 | 8.50 |
| 03-2022 | 15.86 | 25.44 | 3.43 |
| Amount in ₹ Crore | |||
Objects of the Issue
The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
- To Meet Working Capital Requirements
- Funding investments for acquisitions & general corporate purposes
Remus Pharmaceuticals Ltd IPO Promoter Holding
| Pre Issue Share Holding | 23.04% |
| Post Issue Share Holding | 16.97% |
Remus Pharmaceuticals Ltd IPO Subscription Status (Bidding Detail)
The Remus Pharmaceuticals Ltd IPO is subscribed 40.9139 times on NaN Invalid undefined 05:00:00 PM. The public issue subscribed 0 times in the retail category, 0 times in the QIB category, and 0 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | QIB | NII | Retail | Employee | Total |
| Subscription (times) | - | - | - | - | 40.9139 |
Remus Pharmaceuticals Ltd IPO Prospectus
Remus Pharmaceuticals Ltd IPO Listing Date
| BSE Script | 78788 |
| NSE Symbol | REMUS |
| Listing In | - |
| ISIN | INE0O5T01011 |
| IPO Price | ₹1,229 |
| Face Value | ₹10 |
Company Contact Information
1101 to 1103 South Tower One42B/H Ashok Vatika Amblibopal Rd,Ahmedabad-380054
Phone: 91-079-29999857
Email: cs@remuspharma.com
Website: https://www.remuspharma.com
Remus Pharmaceuticals Ltd IPO Registrar
Email: remuspharmaceuticals.ipo@linkintime.co.in
Website: www.linkintime.co.in
Remus Pharmaceuticals Ltd IPO Lead Manager(s)
- Beeline Capital Advisors Pvt Ltd
FAQ
What is the issue size of Remus Pharmaceuticals Ltd IPO?
I have pre-applied for Remus Pharmaceuticals Ltd IPO. When will my order get placed?
In case of pre-apply, your IPO order will be placed on the Exchange as soon as the official bidding for TBI Corn Ltd IPO begins. You will receive a UPI request within 24 hours after the bidding period opens.